- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- IPO Date
- Aug 15, 2022
Highlights
- EPS (TTM)
- -$2.40
- Total Revenue (TTM)
- $2.98M
- Gross Profit (TTM)
- $522.36K
- EBITDA (TTM)
- -$7.26M
- Year Range
- $0.90 - $4.97
- ROA (TTM)
- -85.67%
- ROE (TTM)
- -97.04%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
LUCY Performance Chart
Innovative Eyewear Inc. (LUCY) is down 4.7% since the beginning of the year. At $1 per share, LUCY is trading 80.9% below its 52-week high of $5.
Loading charts...
Returns By Period
Innovative Eyewear Inc. (LUCY) has returned -4.67% so far this year and -69.50% over the past 12 months.
Innovative Eyewear Inc.
- 1D
- -5.47%
- 1M
- -7.87%
- YTD
- -4.67%
- 6M
- -28.57%
- 1Y
- -69.50%
- 3Y*
- -70.65%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.13%
- 1M
- 5.25%
- YTD
- 11.16%
- 6M
- 11.43%
- 1Y
- 28.20%
- 3Y*
- 21.12%
- 5Y*
- 12.66%
- 10Y*
- 13.75%
LUCY Monthly Returns History
Based on dividend-adjusted daily data since Aug 15, 2022, LUCY's average daily return is +0.28%, while the average monthly return is -1.89%.
Historically, 28% of months were positive and 72% were negative. The best month was May 2024 with a return of +323.8%, while the worst month was Jul 2024 at -58.0%. The longest winning streak lasted 2 consecutive months, and the longest losing streak was 6 months.
On a daily basis, LUCY closed higher 40% of trading days. The best single day was May 24, 2024 with a return of +428.5%, while the worst single day was May 28, 2024 at -58.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 14.40% | -1.75% | -2.68% | -3.67% | -0.95% | -8.65% | -4.67% | ||||||
| 2025 | 10.77% | -17.61% | -42.09% | -25.77% | 65.28% | -33.54% | -3.30% | -5.85% | 0.00% | -10.36% | -13.87% | -33.12% | -79.75% |
| 2024 | 1.92% | -11.58% | -28.20% | -26.96% | 323.82% | -41.43% | -57.98% | 20.91% | 66.00% | -1.80% | -18.61% | -26.28% | -41.69% |
| 2023 | -0.58% | 29.21% | -7.95% | 45.68% | -27.97% | -47.38% | -11.13% | -22.63% | -8.52% | -25.34% | 2.36% | -1.88% | -69.20% |
| 2022 | -48.56% | -54.13% | 4.32% | -20.69% | 19.13% | -76.74% |
Benchmark Metrics
Innovative Eyewear Inc. has an annualized alpha of 68.97%, beta of 1.08, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since August 16, 2022.
- This stock participated in 267.19% of S&P 500 Index downside but only -59.42% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 68.97%
- Beta
- 1.08
- R²
- 0.00
- Upside Capture
- -59.42%
- Downside Capture
- 267.19%
Return for Risk
Risk / Return Rank
LUCY ranks 9 for risk / return — in the bottom 9% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Innovative Eyewear Inc. (LUCY) and compare them to S&P 500 Index.
| LUCY | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.67 | 2.39 | -3.06 |
Sortino ratioReturn per unit of downside risk | -1.22 | 3.25 | -4.47 |
Omega ratioGain probability vs. loss probability | 0.85 | 1.43 | -0.58 |
Calmar ratioReturn relative to maximum drawdown | -0.95 | 3.11 | -4.06 |
Martin ratioReturn relative to average drawdown | -1.23 | 14.38 | -15.61 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Innovative Eyewear Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Innovative Eyewear Inc. was 99.21%, occurring on May 15, 2026. The portfolio has not yet recovered.
The current Innovative Eyewear Inc. drawdown is 99.19%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -99.21%May 2026 | 3y 9mo | — | 3y 9moAug 2022 - now |
Drawdown Indicators
| LUCY | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.21% | -56.78% | -42.43% |
Max Drawdown (1Y)Largest decline over 1 year | -73.65% | -9.10% | -64.55% |
Max Drawdown (3Y)Largest decline over 3 years | -97.88% | -18.90% | -78.98% |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.19% | 0.00% | -99.19% |
Average DrawdownAverage peak-to-trough decline | -88.99% | -10.72% | -78.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 56.47% | 1.97% | +54.50% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Innovative Eyewear Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Innovative Eyewear Inc. is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for LUCY relative to other companies in the Medical Instruments & Supplies industry. Currently, LUCY has a P/S ratio of 1.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with LUCY
Add Innovative Eyewear Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with LUCY